Report : MENAT Butterfly Needles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Blood Collection, Blood Transfusion, Venipuncture, IV Rehydration, and Delivery of Medications) and End User (Hospitals, Clinics, Blood Banks, and Others)
IV Rehydration Segment to Lead MENAT Butterfly Needles Market
According to our latest study on "Butterfly Needles Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Application, and End User," the market was valued at US$ 8,887.40 thousand in 2021 and is likely to be valued at US$ 14,615.34 thousand by 2028; it is estimated to grow at a CAGR of 7.5% from 2022 to 2028. The growth of the MENAT butterfly needles market is majorly driven by growing prevalence of chronic diseases and rising cases of genetic blood disorders. However, the risk associated with butterfly needlestick injuries is hampering the market growth.
Growing Prevalence of Chronic Diseases
Butterfly needles are devices used for drawing blood or administering medications in veins. Patients who may be difficult to venipuncture, such as older adults, infants, and children, are often given butterfly needles. A butterfly needle is also known as a winged infusion set or a scalp vein set, as there are plastic wings on either side of the hollow needle. With their winged tubing structure, which allows greater flexibility, butterfly needles are much easier to use and less painful. Additionally, butterfly needles are commonly used to draw blood or administer medication for babies, young children, and the elderly.
According to a research article published in PLOS One in April 2020, in the Middle East, North Africa, and Turkey (MENAT) region, chronic diseases are most prevalent among those over 60, with 0.8% in the UAE and 10.6% in Turkey at risk. With continued improvements in life expectancy, these percentages are predicted to grow significantly by 2030 due to the demographic transition. As a result of this demographic effect, the population is highly susceptible to diabetes, cardiovascular disorders, autoimmune disorders, various types of cancer, and bleeding disorders such as hemophilia or von Willebrand disease, which are the leading causes of death and disability in the MENAT region. There is a growing prevalence of obesity in Bahrain, Egypt, Jordan, Kuwait, Saudi Arabia, and the UAE. Almost 25% of the MENA population suffers from hypertension. It is necessary to sample the blood of patients suffering from chronic diseases frequently.
According to the National Library of Medicine (NLM), in 2021, in Saudi Arabia, bleeding symptoms such as epistaxis (25%), menorrhagia (47%), easy bruising (18%), and prolonged bleeding from dental extractions (18%) have been reported among adults. The overall prevalence of bleeding disorders was 74.5%. The use of butterfly needles to draw blood in patients with bleeding disorders reduces excessive bleeding.
Diabetes is another life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. According to the International Diabetes Federation (IDF), in 2021, there were 73 million adults living with diabetes in the Middle East and North Africa region. The number is anticipated to increase to 95 million by 2030 and 136 million by 2045. Often, insulin is administered through butterfly needles, as they are smaller and thinner than an intravenous (IV) catheter and have smaller gauge sizes, ranging from 18 to 27 on average.
Thus, the growing prevalence of chronic diseases that require blood draws, long-term medications, and drug infusions is boosting the butterfly needles market growth in MENAT
B. Braun SE, Becton Dickinson and Co, Nipro Corp, Cardinal Health Inc, Medline Industries Inc, Terumo Corp, SB-Kawasumi Laboratories Inc, and ICU Medical Inc are among the leading companies operating in the butterfly needles market.
The report segments the butterfly needles market as follows:
Based on application, the butterfly needles market is segmented into blood collection, blood transfusion, venipuncture, IV rehydration, and delivery of medications. The blood collection segment held the largest share of the market in 2021. However, the IV rehydration segment is anticipated to register the highest CAGR during the forecast period. Based on end user, the butterfly needles market is segmented into hospitals, clinics, blood banks, and others. The hospitals segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period. The MENAT butterfly needles market is segmented into Saudi Arabia, the UAE, South Africa, Turkey, Algeria, Morocco, Egypt, Qatar, and the Rest of MENAT.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org